Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07422987 · ClinicalTrials.gov registry record

GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women

A clinical trial of Body Composition and GLP-1, sponsored by University of Kansas Medical Center.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT07422987 is a study of Body Composition and GLP-1 that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 50 participants, below the 114-participant average among 20 other Body Composition trials with a reported enrollment target (56% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07422987, a study of Body Composition and GLP-1, is actively recruiting participants, sponsored by University of Kansas Medical Center.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

This study is designed with the interest to learn on the effects of estrogen levels and how it affects body compositions and muscle function in midlife women who are taking a GLP-1RA for weight loss.

Study Locations (1)

Kansas

  • The University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2026-02-12
Est. Completion 2027-06-30

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT07422987

The ClinicalTrials.gov registry entry for NCT07422987 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 114-participant average among 20 other Body Composition trials with a reported enrollment target (56% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Body Composition appearing as the primary indexed condition, and to 0 interventions.

NCT07422987 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.

Frequently Asked Questions

What is clinical trial NCT07422987 about?

NCT07422987 is a clinical study titled "GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women". This study is designed with the interest to learn on the effects of estrogen levels and how it affects body compositions and muscle function in midlife women who are taking a GLP-1RA for weight loss.

What is the current status of trial NCT07422987?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-02-12. Estimated completion is 2027-06-30.

What conditions does trial NCT07422987 study?

This clinical trial studies the following conditions: Body Composition, GLP-1, Muscle Function, Estrogen Level.

Who is sponsoring clinical trial NCT07422987?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07422987 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Composition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.